Skip to main content
SpringerLink
Log in

Adalimumab/methotrexate

Cytomegalovirus oesophagitis and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nichols L, et al. A NOVEL THERAPY FOR A RARE CONDITION: CONTINUOUS ANAKINRA INFUSION FOR A PATIENT WITH SERONEGATIVE RHEUMATOID ARTHRITIS AND MACROPHAGE ACTIVATION SYNDROME. Journal of General Internal Medicine 38 (Suppl. 2): 23 Jun 2023. Available from: URL: https://link.springer.com/article/10.1007/s11606-023-08226-z [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/methotrexate. Reactions Weekly 1969, 24 (2023). https://doi.org/10.1007/s40278-023-44490-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44490-6

Search

Navigation